)
Ingersoll Rand (IR) investor relations material
Ingersoll Rand Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 orders rose 21% to $2,345.1M, including 18.2% organic growth; revenue increased 5.6% to $2,064.9M, including 3.9% organic growth.
Adjusted EBITDA was $584.4M, up 7.3%; excluding IEEPA tariff refunds, it was $552M, while adjusted EPS was $1.01, up 17%.
Improved demand across short-, medium- and long-cycle businesses, plus a ~$195M data-center order, supported strong orders and a 1.14x book-to-bill.
Financial highlights
Q3 revenue was $2,064.9M versus $1,955.0M; growth included $76.0M organic, $28.2M from acquisitions and $5.7M from favorable FX.
Adjusted EBITDA was $584.4M versus $544.6M; margin was 28.3% versus 27.9%. Excluding tariff refunds, EBITDA was $552M with a 26.7% margin.
Adjusted diluted EPS was $1.07 versus $0.86; excluding tariff refunds, it was $1.01, up 17%.
Reported net income was $671.6M versus $245.8M, including a substantial ILC Dover-related recovery.
Free cash flow was $623.3M versus $325.5M; Q3 collections included $162.5M of ILC Dover-related recoveries.
Outlook and guidance
FY2026 revenue growth guidance is 5.5%–7.0%, comprising 2%–3.5% organic growth, ~2.5% from M&A and ~1% from FX.
FY2026 adjusted EBITDA guidance, excluding Q3 IEEPA tariff refunds, is $2,130M–$2,190M; management expects to finish in the bottom half amid inflation and China pricing pressure.
FY2026 adjusted EPS guidance, excluding Q3 tariff refunds, increased to $3.58–$3.70; assumptions include ~20% adjusted tax, ~390.5M diluted shares and ~$230M net interest expense.
Free cash flow conversion is expected above 100% of adjusted net income including ILC Dover recoveries; underlying conversion excluding recoveries is ~95%, with capex at ~2% of sales.
Q4 organic revenue growth is expected at 2%+; ITS margins are expected to improve ~100 bps sequentially, supported by price-cost, volume and productivity.
- Growth accelerates with strong orders, margin recovery, and disciplined M&A fueling future upside.IR
Morgan Stanley's 14th Annual Laguna Conference - Order momentum and margin recovery are accelerating, driven by volume growth and recurring revenue.IR
Jefferies Global Industrials Conference 2026 - Order momentum and recurring revenue growth accelerate, with margins set to improve into 2027.IR
Deutsche Bank’s Chicago Industrials Summit - Q2 2026 delivered strong growth, higher guidance, and robust liquidity and M&A activity.IR
Q2 2026 - Global expansion, recurring revenue, and innovation drive growth amid prudent guidance.IR
Citi's Global Industrial Tech & Mobility Conference 2026 - Q1 organic order growth, robust backlog, and recurring revenue expansion drive margin gains.IR
18th Annual Global Transportation & Industrials Conference - IRX, disciplined bolt-on M&A, and life sciences expansion support growth and value creation.IR
44th Annual J.P. Morgan Healthcare Conference - Q3 2025 saw 5.1% revenue growth, margin resilience, and strong cash flow despite tariff headwinds.IR
Q3 2025 - Record Q1 orders, robust cash flow, and expanded buyback highlight strong financial momentum.IR
Q1 2025
)
)
)
)
)
)
)
)